News
Bayer files elinzanetant as a non-hormonal treatment for menopausal symptoms, with Astellas' first-to-market Veozah in its sights Skip to main content Friday 27 June 2025 . BlueSky linkedin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback